Gabapentin
- Generic Name
- Gabapentin
- Brand Names
- Gralise, Neurontin
- Drug Type
- Small Molecule
- Chemical Formula
- C9H17NO2
- CAS Number
- 60142-96-3
- Unique Ingredient Identifier
- 6CW7F3G59X
- Background
Gabapentin is a structural analogue of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA) that was first approved for use in the United States in 1993. It was originally developed as a novel anti-epileptic for the treatment of certain types of seizures - today it is also widely used to treat neuropathic pain. Gabapentin has some stark advantages ...
- Indication
In the United States, gabapentin is officially indicated for the treatment of postherpetic neuralgia in adults and for the adjunctive treatment of partial-onset seizures, with or without secondary generalization, in patients 3 years of age and older. In Europe, gabapentin is indicated for adjunctive therapy in the treatment of partial-onset seizures, with or...
- Associated Conditions
- Partial-Onset Seizures, Peripheral Neuropathic Pain, Postherpetic Neuralgia
- Associated Therapies
- -
Comparative Study Of Pregabalin And Gabapentin As Adjunctive Therapy In Subjects With Partial Seizures
- Conditions
- Interventions
- First Posted Date
- 2007-10-02
- Last Posted Date
- 2021-01-22
- Target Recruit Count
- 482
- Registration Number
- NCT00537940
- Locations
- 🇸🇻
Clinica de Especialidades Neurologicas, San Salvador, El Salvador
🇬🇹Private Office, Guatemala, Guatemala
🇸🇻Instituto de Neurociencias, San Salvador, El Salvador
Gabapentin for the Treatment of Neuroleptic-Induced Tremor
- Conditions
- First Posted Date
- 2007-09-21
- Last Posted Date
- 2007-09-24
- Lead Sponsor
- Minneapolis Veterans Affairs Medical Center
- Target Recruit Count
- 40
- Registration Number
- NCT00533455
- Locations
- 🇺🇸
Minneapols VA Medical Center, Minneapolis, Minnesota, United States
Study of Gabapentin Extended Release (G-ER) in the Treatment of Vasomotor (Hot Flashes/Hot Flushes) Symptoms in Postmenopausal Women
- Conditions
- Interventions
- First Posted Date
- 2007-08-06
- Last Posted Date
- 2011-06-08
- Lead Sponsor
- Depomed
- Target Recruit Count
- 108
- Registration Number
- NCT00511953
Gabapentin Treatment of Benzodiazepine Abuse in Methadone Maintenance Patients
- Conditions
- Interventions
- First Posted Date
- 2007-01-11
- Last Posted Date
- 2019-04-24
- Lead Sponsor
- New York State Psychiatric Institute
- Target Recruit Count
- 19
- Registration Number
- NCT00420771
- Locations
- 🇺🇸
Bridge Plaza Treatment and Rehabilitation Clinic, Long Island City, New York, United States
Gabapentin Treatment of Cannabis Dependence
- First Posted Date
- 2006-11-02
- Last Posted Date
- 2017-02-10
- Lead Sponsor
- The Scripps Research Institute
- Target Recruit Count
- 50
- Registration Number
- NCT00395044
- Locations
- 🇺🇸
The Scripps Research Institute, La Jolla, California, United States
To Evaluate if the Medication Gabapentin Lessens Vulvar Pain
- Conditions
- Interventions
- First Posted Date
- 2006-10-19
- Last Posted Date
- 2017-07-31
- Lead Sponsor
- Colleen Stockdale
- Target Recruit Count
- 9
- Registration Number
- NCT00390013
- Locations
- 🇺🇸
University of Iowa Hospital and Clinics, Iowa City, Iowa, United States
An Open-Label Comparison of Duloxetine to Other Alternatives for the Management of Diabetic Peripheral Neuropathic Pain
- Conditions
- Interventions
- First Posted Date
- 2006-10-11
- Last Posted Date
- 2011-07-26
- Lead Sponsor
- Eli Lilly and Company
- Target Recruit Count
- 407
- Registration Number
- NCT00385671
- Locations
- 🇩🇪
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Siegen, Germany
Comparing Gabapentin and Amitriptyline for the Treatment of Neuropathic Pain in Children and Adolescents
- First Posted Date
- 2006-04-07
- Last Posted Date
- 2020-10-20
- Lead Sponsor
- The Hospital for Sick Children
- Target Recruit Count
- 34
- Registration Number
- NCT00312260
- Locations
- 🇨🇦
The Hospital for Sick Children, Toronto, Ontario, Canada
Preanalgesic Effect of Gabapentin in Total Knee Repair
- First Posted Date
- 2006-01-19
- Last Posted Date
- 2016-10-26
- Lead Sponsor
- Texas Health Resources
- Target Recruit Count
- 24
- Registration Number
- NCT00279487
- Locations
- 🇺🇸
Presbyterian Hospital of Dallas, Dallas, Texas, United States
The Effect of Gabapentin on the Sensation and Impact of Tinnitus
- Conditions
- First Posted Date
- 2005-11-22
- Last Posted Date
- 2005-11-22
- Lead Sponsor
- Tinnitus Research Consortium
- Target Recruit Count
- 40
- Registration Number
- NCT00257270
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.